SCHEMBL13291114

SCHEMBL13291114

Cn1c2ccccc2c2cc(N(c3ccc(-c4cccc5ccccc45)cc3)c3ccc(-c4c5ccccc5c(-c5ccccc5)c5ccccc45)cc3)ccc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 2/20 0.39
▸ KDM4E B2RXH2 2/20 0.38
▸ KMT2A Q03164 3/20 0.36
▸ MAPT P10636 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ PABPC1 P11940 1/20 0.36
▸ GPR3 P46089 1/20 0.36
▸ MCL1 Q07820 1/20 0.36
▸ ACMSD Q8TDX5 1/20 0.36
▸ CA12 O43570 1/20 0.35
▸ CA1 P00915 1/20 0.35
▸ CA2 P00918 1/20 0.35
▸ CA9 Q16790 1/20 0.35
▸ LMNA P02545 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ PPARG P37231 5/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13291115 0.89 NPY5R (0.44) HSD17B10KDM4EKMT2AMAPTMEN1
SCHEMBL13291116 0.88 PPARG (0.37) MCL1ACMSDCA12CA1CA2
SCHEMBL14521297 0.88 KDM4E (0.44) HSD17B10KDM4EKMT2AMAPTMEN1
SCHEMBL13290999 0.88 KDM4E (0.40) KDM4EKMT2AMAPTL3MBTL1MCL1
SCHEMBL13291034 0.87 KDM4E (0.39) KDM4EKMT2AMAPTL3MBTL1MCL1
SCHEMBL13291060 0.87 KDM4E (0.39) KDM4EKMT2AMAPTL3MBTL1MCL1
SCHEMBL13291036 0.87 KDM4E (0.39) KDM4EKMT2AMAPTL3MBTL1MCL1
SCHEMBL14362633 0.87 GPR3 (0.46) HSD17B10KDM4EKMT2AMAPTMEN1
SCHEMBL13291067 0.86 KDM4E (0.41) KDM4EKMT2AMAPTL3MBTL1MCL1
SCHEMBL13291070 0.86 KDM4E (0.38) KDM4EKMT2AMAPTL3MBTL1MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100156957-A1 ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENTS, LIGHT-EMITTING DEVICES, ELECTRONIC DEVICES, AND LIGHTING DEVICES USING THE ANTHRACENE DERIVATIVE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2010-06-24 — — US disclosed
US-20100156957-A1 ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENTS, LIGHT-EMITTING DEVICES, ELECTRONIC DEVICES, AND LIGHTING DEVICES USING THE ANTHRACENE DERIVATIVE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2010-06-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100156957-A1 ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENTS, LIGHT-EMITTING DEVICES, ELECTRONIC DEVICES, AND LIGHTING DEVICES USING THE ANTHRACENE DERIVATIVE GLB1, CYP1A1, CRY1 HSD17B10 1047/4885KDM4E 3427/4885KMT2A 3618/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback